2019
DOI: 10.18087/cardio.2019.10.2680
|View full text |Cite
|
Sign up to set email alerts
|

Hemostatic Gene Polymorphisms in Acute Coronary Syndrome with Nonobstructive Coronary Atherosclerosis

Abstract: Резюме Цель исследования. Изучить распределение полиморфизмов генов системы свертывания крови, неблагоприятных в отношении риска развития тромбозов, и их влияние на сывороточные показатели крови системы гемостаза у больных с невыраженным атеросклерозом коронарных артерий (НАКА) при остром коронарном синдроме (ОКС). Материалы и методы. Нерандомизированное открытое исследование выполнено в отделении неотложной кардиологии. В исследование были включены больные с ОКС старше 18 лет с интактными коронарными артериям… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Screening for the presence of hereditary thrombophilia in MINOCA patients showed an incidence of about 14–33% [ 12 , 14 , 15 ], including factor V Leiden (− 12%), protein C and S deficiency, and factor XII deficiency (− 3%). A number of studies report the prevalence of other hereditary thrombophilia, such as hyperhomocysteinemia (HHC), increased levels of von Willebrand factor (VWF), and plasminogen deficiency, and their role in the development of thrombosis in patients with MINOCA [ 16 , 17 ]. The prevalence of the acquired thrombotic disorders (antiphospholipid syndrome, myeloproliferative diseases) is about 20% [ 12 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Screening for the presence of hereditary thrombophilia in MINOCA patients showed an incidence of about 14–33% [ 12 , 14 , 15 ], including factor V Leiden (− 12%), protein C and S deficiency, and factor XII deficiency (− 3%). A number of studies report the prevalence of other hereditary thrombophilia, such as hyperhomocysteinemia (HHC), increased levels of von Willebrand factor (VWF), and plasminogen deficiency, and their role in the development of thrombosis in patients with MINOCA [ 16 , 17 ]. The prevalence of the acquired thrombotic disorders (antiphospholipid syndrome, myeloproliferative diseases) is about 20% [ 12 , 14 ].…”
Section: Introductionmentioning
confidence: 99%